Microbix Biosystems Stock Target Price
| MBXBF Stock | USD 0.21 0.01 4.55% |
Fundamental analysis of Microbix Biosystems allows traders to better anticipate movements in Microbix Biosystems' stock price by examining its financial health and performance throughout various phases of its business cycle.
Microbix |
Microbix Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbix Biosystems' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Microbix Biosystems could also be used in its relative valuation, which is a method of valuing Microbix Biosystems by comparing valuation metrics of similar companies.Microbix Biosystems is currently under evaluation in target price category among its peers.
Microbix Fundamentals
| Return On Equity | -0.0171 | |||
| Return On Asset | 0.0056 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 37.83 M | |||
| Shares Outstanding | 138.45 M | |||
| Shares Owned By Insiders | 13.45 % | |||
| Shares Owned By Institutions | 1.08 % | |||
| Price To Earning | 37.00 X | |||
| Price To Book | 2.48 X | |||
| Price To Sales | 2.14 X | |||
| Revenue | 19.08 M | |||
| Gross Profit | 11.12 M | |||
| EBITDA | 3.73 M | |||
| Net Income | 1.79 M | |||
| Cash And Equivalents | 14.16 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 4.71 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 7.84 X | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | 3.47 M | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.15 | |||
| Market Capitalization | 33.04 M | |||
| Total Asset | 33.15 M | |||
| Z Score | 4.2 | |||
| Net Asset | 33.15 M |
About Microbix Biosystems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbix Biosystems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbix Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbix Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Microbix OTC Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.